These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38750677)

  • 1. Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes.
    Ullah A; Chen Y; Singla RK; Cao D; Shen B
    Pharmacol Res; 2024 Jun; 204():107213. PubMed ID: 38750677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.
    Ullah A; Jiao W; Shen B
    Cell Mol Biol Lett; 2024 May; 29(1):73. PubMed ID: 38745115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
    Engl T; Relja B; Blumenberg C; Müller I; Ringel EM; Beecken WD; Jonas D; Blaheta RA
    Life Sci; 2006 Mar; 78(16):1784-93. PubMed ID: 16263140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
    Yu X; Huang Y; Collin-Osdoby P; Osdoby P
    J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10.
    Li W; Ma JA; Sheng X; Xiao C
    World J Surg Oncol; 2021 Nov; 19(1):329. PubMed ID: 34794429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
    Sun X; Chen Q; Zhang L; Chen J; Zhang X
    Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXC chemokines and prostate cancer: growth regulators and potential biomarkers.
    Lentsch AB
    Future Oncol; 2006 Oct; 2(5):651-8. PubMed ID: 17026456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics Analysis of Potential Therapeutic Targets and Prognostic Biomarkers amid CXC Chemokines in Ovarian Carcinoma Microenvironment.
    Jin Y; Lin Q; Fei H; Xue L; Li L; Xi Q; Jiang H
    J Oncol; 2021; 2021():8859554. PubMed ID: 33763130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive dysregulation of transcription factors NF-kappa B and STAT1 in prostate cancer cells causes proangiogenic production of CXC chemokines.
    Shen H; Lentsch AB
    Am J Physiol Cell Physiol; 2004 Apr; 286(4):C840-7. PubMed ID: 14656722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXC chemokines influence immune surveillance in immunological disorders: Polycystic ovary syndrome and endometriosis.
    Ullah A; Wang MJ; Wang YX; Shen B
    Biochim Biophys Acta Mol Basis Dis; 2023 Jun; 1869(5):166704. PubMed ID: 37001703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CXC chemokines and their receptors in cancer.
    Vandercappellen J; Van Damme J; Struyf S
    Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells.
    Moore BB; Arenberg DA; Stoy K; Morgan T; Addison CL; Morris SB; Glass M; Wilke C; Xue YY; Sitterding S; Kunkel SL; Burdick MD; Strieter RM
    Am J Pathol; 1999 May; 154(5):1503-12. PubMed ID: 10329603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.
    Korbecki J; Kojder K; Kapczuk P; Kupnicka P; Gawrońska-Szklarz B; Gutowska I; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
    Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Analysis of CXC Chemokine-Vascular Endothelial Growth Factor A Network in Colonic Adenocarcinoma from the Perspective of Angiogenesis.
    Situ Y; Lu X; Cui Y; Xu Q; Deng L; Lin H; Shao Z; Chen J
    Biomed Res Int; 2022; 2022():5137301. PubMed ID: 36246978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
    Cabrero-de Las Heras S; Martínez-Balibrea E
    World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells.
    Kulbe H; Thompson R; Wilson JL; Robinson S; Hagemann T; Fatah R; Gould D; Ayhan A; Balkwill F
    Cancer Res; 2007 Jan; 67(2):585-92. PubMed ID: 17234767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
    Guo L; Cui ZM; Zhang J; Huang Y
    Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated CXCL14 is associated with poor survival outcomes and promotes ovarian cancer cells proliferation.
    Li X; Zhao L; Meng T
    Cell Biochem Funct; 2020 Jul; 38(5):613-620. PubMed ID: 32077118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of CXC chemokines in epithelial ovarian cancer.
    Rainczuk A; Rao J; Gathercole J; Stephens AN
    Reproduction; 2012 Sep; 144(3):303-17. PubMed ID: 22771929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.